198 related articles for article (PubMed ID: 15331725)
1. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.
Yang L; Hakoda M; Iwabuchi K; Takeda T; Koike T; Kamatani N; Takada K
J Virol; 2004 Sep; 78(18):9918-23. PubMed ID: 15331725
[TBL] [Abstract][Full Text] [Related]
2. The B cell repertoire in rheumatoid arthritis. I. Frequency of EBV-inducible circulating precursors producing autoantibodies.
Moynier M; Abderrazik M; Rucheton M; Combe B; Sany J; Brochier J
J Autoimmun; 1991 Aug; 4(4):631-49. PubMed ID: 1663752
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
Iwakiri D; Takada K
J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
[TBL] [Abstract][Full Text] [Related]
4. The specificity of synovial IgM rheumatoid factors (RF) for genetically engineered IgG antibodies is not affected by the method used to immortalize RF-producing B cells.
Bonagura VR; Kwong T; Kenny T; Robbins DL; Morrison SL
Scand J Immunol; 1999 Jan; 49(1):106-11. PubMed ID: 10023865
[TBL] [Abstract][Full Text] [Related]
5. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines.
Satoh T; Fukuda M; Sairenji T
Virus Genes; 2002; 25(1):15-21. PubMed ID: 12206304
[TBL] [Abstract][Full Text] [Related]
7. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines.
Takada K
Int J Cancer; 1984 Jan; 33(1):27-32. PubMed ID: 6319296
[TBL] [Abstract][Full Text] [Related]
9. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and responses of EBV immortalized B cells from periodontal disease patients.
Celenligil H; Ebersole JL
Oral Dis; 1997 Dec; 3(4):262-71. PubMed ID: 9643223
[TBL] [Abstract][Full Text] [Related]
11. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
12. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.
Kuhn-Hallek I; Sage DR; Stein L; Groelle H; Fingeroth JD
Blood; 1995 Mar; 85(5):1289-99. PubMed ID: 7858259
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.
Fukuda M; Satoh TA; Takanashi M; Hirai K; Ohnishi E; Sairenji T
Viral Immunol; 2000; 13(2):215-29. PubMed ID: 10893001
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.
Brisslert M; Rehnberg M; Bokarewa MI
Immunology; 2013 Dec; 140(4):421-9. PubMed ID: 23844744
[TBL] [Abstract][Full Text] [Related]
15. Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
Levhar N; Ungar B; Kopylov U; Fudim E; Yavzori M; Picard O; Amariglio N; Chowers Y; Shemer-Avni Y; Mao R; Chen MH; Ye Z; Eliakim R; Ben-Horin S
Inflamm Bowel Dis; 2020 Aug; 26(9):1330-1339. PubMed ID: 32322878
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
17. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Epstein-Barr virus on host gene expression in Burkitt's lymphoma cell lines].
Broderick P; Hubank M; Sinclair A
Ai Zheng; 2009 Aug; 28(8):813-21. PubMed ID: 19664326
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
20. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
